Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:18 AM
Ignite Modification Date:
2025-12-25 @ 4:18 AM
NCT ID:
NCT04295720
Eligibility Criteria:
Inclusion Criteria:
* Adult (\>=18).
* PCCI diagnosis (see information below).
* Right Handed (We will not enroll left-handed dominant people because they tend to have more symmetric brain function and thus targeting the left frontal region may not be as effective.)
* English speaking.
* Cancer treatment completed and considered curative with the exception of endocrine therapy after chemotherapy.
* Able to attend daily intervention (Monday-Friday) for 2 weeks.
* Not enrolled in another interventional study within 6 months prior to beginning this study.
Exclusion Criteria:
* Pregnancy or thinking of becoming pregnant.
* Undergoing active treatment for cancer.
* Routine contraindications for MRI (including incompatible medical implants or metal fragments in the body at risk for migration or heating with application of the magnetic field) including severe claustrophobia.
* History of brain metastasis or other brain tumor.
* History of stroke or traumatic brain injury.
* Frequent or severe headaches.
* Cognitive or mood disorder prior to chemotherapy (i.e. dementia or depression).
* History of epilepsy, or other seizure disorders.
* History mental health disorders, such as substance misuse, bipolar disorder or psychosis.
* Taking medication for seizures or that could lower seizure threshold if withdrawn.
* Inability to complete neuropsychological testing.
* Prior treatment with rTMS. We will enroll subjects without prior experience with rTMS.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04295720
Study Brief:
Protocol Section:
NCT04295720